American Enterprise Institute’s “AEIdeas”: More substandard medicines drive faster resistance
Roger Bate, an author and visiting scholar at the American Enterprise Institute, discusses how substandard-quality medicines contribute to drug resistance, using tuberculosis as an example. He writes, “If we’re going to win the global fight against TB, we need better oversight of TB medicine manufacturing and information on failing companies so physicians and patients can boycott certain manufacturers…” (10/29).